These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 35284)

  • 1. [Immunological aspects of nucleolar activation. III. Changes in nucleolar activation after application of S III pneumococcal polysaccharide in vivo].
    Blazek J
    Cesk Patol; 1979 Feb; 15(1):41-8. PubMed ID: 35284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenic properties of the thymus-independent antigen pneumococcal polysaccharide S3.
    Coutinho A; Möller G
    Eur J Immunol; 1973 Oct; 3(10):608-13. PubMed ID: 4148779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunopathological aspects of nucleolar activation. 1. Changes of nucleolar activation during the course of primary immune response].
    Blazek J
    Cesk Patol; 1977 May; 13(1-2):52-63. PubMed ID: 74293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphology of the antibody response to pneumococcal polysaccharide in mice.
    Hajdu I
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):226-34. PubMed ID: 43878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of activity of lymphocytes estimated from nucleolar morphology in infants.
    Haníková M; Lodinová R; Miler I
    Folia Microbiol (Praha); 1978; 23(1):72-4. PubMed ID: 624512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of concanavalin A on lymphocyte interactions involved in the antibody response to type III pneumococcal polysaccharide. II. Ability of suppressor T cells to act on both B cells and amplified T cells to limit the magnitude of the antibody response.
    Markham RB; Reed ND; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1977 Sep; 119(3):1163-8. PubMed ID: 19533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement for B cells for activation of contrasuppressor T cells by type III pneumococcal polysaccharide.
    Braley-Mullen H
    J Immunol; 1990 Apr; 144(7):2465-72. PubMed ID: 2319128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the antibody response to type III pneumococcal polysaccharide. V. Ontogeny of factors influencing the magnitude of the plaque-forming cell response.
    Morse HC; Prescott B; Cross SS; Stashak PW; Baker PJ
    J Immunol; 1976 Feb; 116(2):279-87. PubMed ID: 2633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: Factors influencing the response of mice to type III pneumococcal polysaccharide.
    Warr GW
    J Immunol; 1976 Apr; 116(4):1196-7. PubMed ID: 3608
    [No Abstract]   [Full Text] [Related]  

  • 10. Nucleolar silver-staining patterns related to cell cycle phase and cell generation of PHA-stimulated human lymphocytes.
    Field DH; Fitzgerald PH; Sin FY
    Cytobios; 1984; 41(161):23-33. PubMed ID: 6084580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation.
    Braley-Mullen H
    J Immunol; 1976 Apr; 116(4):904-10. PubMed ID: 3609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrillar centres and condensed nucleolar chromatin in resting and stimulated human lymphocytes.
    Raska I; Rychter Z; Smetana K
    Z Mikrosk Anat Forsch; 1983; 97(1):15-32. PubMed ID: 6636959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cobra venom (CoF) and pneumococcal S III capsular polysaccharide on immunologic humoral response and visceral distribution of antigens.
    Pryjma J; Strzyzewska J
    Arch Immunol Ther Exp (Warsz); 1977; 25(4):469-75. PubMed ID: 22318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary IgG responses to type III pneumococcal polysaccharide. I. Kinetics and antigen requirements.
    Braley-Mullen H
    J Immunol; 1975 Nov; 115(5):1194-8. PubMed ID: 240888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation by haptenic Salmonella polysaccharides of murine and rabbit lymphocytes.
    Bona C; Damais C
    Ann Immunol (Paris); 1975; 126(2):191-9. PubMed ID: 1103719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of amplifier T cells involved in the antibody response to the capsular polysaccharide of type III Streptococcus pneumoniae.
    Taylor CE; Stashak PW; Chiang J; Leiserson WM; Caldes G; Prescott B; Baker PJ
    J Immunol; 1984 Jun; 132(6):3103-8. PubMed ID: 6202773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunopathological aspects of nucleolar activation. II. Changes in nucleolar activation during anamnestic immune response].
    Blazek J
    Cesk Patol; 1978 Nov; 14(4):213-22. PubMed ID: 737796
    [No Abstract]   [Full Text] [Related]  

  • 19. Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide.
    Baker PJ; Amsbaugh DF; Stashak PW; Caldes G; Prescott B
    J Immunol; 1982 Mar; 128(3):1059-62. PubMed ID: 6173416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective sensitivity to hydrocortisone of regulatory functions that determine the magnitude of the antibody response to type III pneumococcal polysaccharide.
    Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1978 Sep; 121(3):829-34. PubMed ID: 29068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.